Clinical Study
Enteral Glutamine Administration in Critically Ill Nonseptic Patients Does Not Trigger Arginine Synthesis
Table 3
Baseline characteristics.
| Baseline parameter | CON | ALA-GLN | (%)/mean (SEM)/median (IQR) | (%)/mean (SEM)/median (IQR) |
| Demographics | | | Sex: male/female (%) | 6/4 (60/40) | 6/4 (60/40) | Age (y) | 65 (6.4) | 57 (5.4) | Length (cm) | 172.6 (3.7) | 176.8 (3.0) | Weight (kg) | 73.2 (5.8) | 77.7 (4.1) | BMI (kg/m2) | 24.2 (1.0) | 24.5 (3.3) | Clinical assessment | | | Type of ICU admission | | | Respiratory insufficiency | 6 (60) | 3 (30) | Cardiogenic shock | 1 (10) | 4 (40) | Neurotrauma | 1 (10) | 0 | Multitrauma | 1 (10) | 2 (20) | Other | 1 (10) | 1 (10) | APACHE II score | 27.0 (2.2) | 25.3 (3.0) | Laboratory measurements at inclusion | | | pH | 7.42 (0.048) | 7.44 (0.027) | pCO2 | 41.4 (10.3) | 43.9 (9.7) | Bicarbonate (mmol/L) | 32.9 (22.0–33.0) | 30.5 (5.3) | Glucose (mmol/L) | 6.6 (0.83) | 7.5 (1.4) | Leukocytes ( µmol/L) | 11.0 (3.1) | 11.8 (4.4) | Bilirubin (µmol/L) | 8.5 (5.0–16.8) | 9 (4.0–11.3) | Creatinine (µmol/L) | 78 (9.7) | 81.8 (13.7) | Urine production (mL/24 h) | 2301 (361) | 2333 (295) |
|
|